Emerging Polygenic Risk Score Tests Demonstrate Potential for Improving Cancer Screening
Although PRS technology and adoption still have a way to go, it is progressing quickly, especially in the cancer and oncology space.
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article